ARCHIVES

DCT Board Okays Recompetition of $15 Million In contract Projects

This article is from The Cancer Letter archive.

Vol. 04 No. 45 | November 10, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988

In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced

July 3, 1981

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Cooperative Groups: Committee Formed To Implement Armitage Report Had A Rough Start

June 12, 1998